Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Rheumatoid Arthritis

Free Subscription Articles published in Clin Rheumatol Retrieve available abstracts of 260 articles: HTML format

Single Articles

October 2025
1. CUI M, Zhang C, Zhou Q, Ji M, et al
   Association of Apolipoprotein E polymorphism with lipoprotein metabolism and cardiovascular disease risk in rheumatoid arthritis patients.
   Clin Rheumatol. 2025 Oct 10. doi: 10.1007/s10067-025-07733.
   PubMed     Abstract available
   
   
   
2. LIU X, Yuan PY, Zhang GH, Bu LH, et al
   The interactions between HLA alleles and immune indicators were associated with the risk of rheumatoid arthritis.
   Clin Rheumatol. 2025 Oct 8. doi: 10.1007/s10067-025-07729.
   PubMed     Abstract available
   
   
   September 2025
3. LAI SW, Kuo YH, Liao KF
   Association between rheumatoid arthritis and thyroid cancer risk: a real-world cohort study using TriNetX.
   Clin Rheumatol. 2025 Sep 29. doi: 10.1007/s10067-025-07668.
   PubMed     Abstract available
   
   
   
4. WANG Q, Anthony DD
   Glucagon-like peptide-1 receptor analog use is associated with reduced thromboembolic events compared with dipeptidyl peptidase-4 inhibitors in rheumatoid arthritis patients: A global retrospective cohort study.
   Clin Rheumatol. 2025 Sep 27. doi: 10.1007/s10067-025-07709.
   PubMed     Abstract available
   
   
   
5. RODRIGUES LSS, Feyo VB, Provinciali LS, Pereira JJ, et al
   Association between tooth loss and clinical complications in rheumatoid arthritis: a pilot study.
   Clin Rheumatol. 2025 Sep 23. doi: 10.1007/s10067-025-07647.
   PubMed     Abstract available
   
   
   
6. SALIEVA RS, Zhumabaeva S, Isakov U, Sakibaev K, et al
   The role of sequential biologic therapy in rheumatoid arthritis: a systematic review and meta-analysis of efficacy, safety, and predictive factors.
   Clin Rheumatol. 2025 Sep 11. doi: 10.1007/s10067-025-07636.
   PubMed     Abstract available
   
   
   
7. ZHU K, Zhang X, Chen G, Zhu Y, et al
   Treatment effectiveness of hydroxychloroquine in patients with primary Sjogren's syndrome: a real-world Study.
   Clin Rheumatol. 2025;44:3591-3603.
   PubMed     Abstract available
   
   
   
8. HUI M, Deng X, Wang J, Qian J, et al
   The association between STAT4 polymorphism and pulmonary arterial hypertension in Chinese patients with primary Sjogren's syndrome.
   Clin Rheumatol. 2025;44:3581-3590.
   PubMed     Abstract available
   
   
   August 2025
9. PRASAD CB, Dhir V, Gupta R, Thomas KN, et al
   Split vs single-dose oral methotrexate in rheumatoid arthritis: a randomized controlled trial (SMART study).
   Clin Rheumatol. 2025 Aug 29. doi: 10.1007/s10067-025-07646.
   PubMed     Abstract available
   
   
   
10. AL-JEDAI A, Al-Mudaiheem H, Alghanim N, Alhomood I, et al
    Transforming rheumatoid arthritis care: dynamic budget impact models with ACR to DAS28 mapping for anti-TNFs, JAK inhibitors, and interleukins.
    Clin Rheumatol. 2025 Aug 21. doi: 10.1007/s10067-025-07644.
    PubMed     Abstract available
    
    
    
11. YIN J, Zhang M, Jia X
    Letter to the editor: clinical significance of serum RAGE levels in anti-CCP-negative rheumatoid arthritis.
    Clin Rheumatol. 2025 Aug 19. doi: 10.1007/s10067-025-07660.
    PubMed    
    
    
    
12. SUNNER S, Jones B, Jones CA, Al Hamarneh YN, et al
    Age-related disparities in biologic therapy initiation among rheumatoid arthritis patients: Insights from a large retrospective cohort study.
    Clin Rheumatol. 2025 Aug 12. doi: 10.1007/s10067-025-07615.
    PubMed     Abstract available
    
    
    
13. LU YC, Chen YC
    Ultrasound of the wrist in low disease rheumatoid arthritis patients: Intercarpal joint is more sensitive than radio-carpal and distal radio-ulnar joint.
    Clin Rheumatol. 2025 Aug 6. doi: 10.1007/s10067-025-07625.
    PubMed     Abstract available
    
    
    
14. CAI T, Tao Y, Pan Q, Yang L, et al
    Integrative GWAS and Mendelian randomization study of rheumatoid arthritis based on the 2019 UK Biobank questionnaire.
    Clin Rheumatol. 2025 Aug 5. doi: 10.1007/s10067-025-07590.
    PubMed     Abstract available
    
    
    
15. LI S, Zhang J, Li J, Liu W, et al
    Nonlinear association between rheumatoid factor and interstitial lung disease risk in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Aug 5. doi: 10.1007/s10067-025-07627.
    PubMed     Abstract available
    
    
    
16. ZHANG Y, Liang Y, Liu M, Liu L, et al
    Identifying plasma proteins and immunocyte phenotypes as risk factors in rheumatoid arthritis: The role of EPHA3 and CD28(+) CD45RA(+) CD8(br) treg cells.
    Clin Rheumatol. 2025 Aug 2. doi: 10.1007/s10067-025-07605.
    PubMed     Abstract available
    
    
    
17. DOZET M, Fugosic Mesic V, Laskarin AM, Drvar V, et al
    Salivary and serum biomarkers profile of patients with rheumatoid arthritis and temporomandibular disorders.
    Clin Rheumatol. 2025 Aug 1. doi: 10.1007/s10067-025-07593.
    PubMed     Abstract available
    
    
    
18. ANYFANTI P, Antza C, Ainatzoglou A, Angeloudi E, et al
    Sodium, potassium intake and urinary sodium-to-potassium ratio in rheumatoid arthritis: association with markers of cardiovascular dysfunction and disease-related parameters.
    Clin Rheumatol. 2025 Aug 1. doi: 10.1007/s10067-025-07608.
    PubMed     Abstract available
    
    
    
19. KOYAMA K, Ohba T, Koizumi R, Haro H, et al
    Prevalence and Predictors of Residual Symptoms in Rheumatoid Arthritis Patients in SDAI Remission: A Cross-Sectional Study Using the Illustrated Okomarigoto Sheet.
    Clin Rheumatol. 2025 Aug 1. doi: 10.1007/s10067-025-07592.
    PubMed     Abstract available
    
    
    July 2025
20. RAO P, Jin S, Zhang B, Li R, et al
    Synovial infiltrating immune cell heterogeneity associated with synovitis severity and systemic disease activity in rheumatoid arthritis: a cross-sectional study.
    Clin Rheumatol. 2025 Jul 30. doi: 10.1007/s10067-025-07565.
    PubMed     Abstract available
    
    
    
21. KOMIYA Y, Sugihara T, Ishizaki T, Kimura N, et al
    The impact of aging and glucocorticoid use on physical function of older rheumatoid arthritis in remission: analysis of a National Database of Rheumatic Disease in Japan.
    Clin Rheumatol. 2025 Jul 30. doi: 10.1007/s10067-025-07599.
    PubMed     Abstract available
    
    
    
22. ZHA X, Liu M, Ruan S, Jiang Y, et al
    Relationship between serum vitamin D levels and pro-inflammatory cytokines in patients with rheumatoid arthritis combined with cardiovascular disease.
    Clin Rheumatol. 2025 Jul 26. doi: 10.1007/s10067-025-07587.
    PubMed     Abstract available
    
    
    
23. MAS MARIN J, Molina-Olano M, Sola NR, Miserachs-Aranda N, et al
    Biosimilars and reference biological medicines in the treatment of rheumatoid arthritis: a multicenter cross-sectional study in Catalonia, Spain.
    Clin Rheumatol. 2025 Jul 24. doi: 10.1007/s10067-025-07568.
    PubMed     Abstract available
    
    
    
24. TUZUN Z, Aydin K, Turk I, Varkal G, et al
    Evaluation of the coalescent lung ultrasound score in rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2025 Jul 24. doi: 10.1007/s10067-025-07589.
    PubMed     Abstract available
    
    
    
25. LI Z, Liu Y, Zhang Y, Zhang Z, et al
    NETs promote fibroblast-like synoviocytes producing IL-6 to enhance T follicular helper cell response in rheumatoid arthritis.
    Clin Rheumatol. 2025 Jul 19. doi: 10.1007/s10067-025-07543.
    PubMed     Abstract available
    
    
    
26. HUANG J, Wang L, Hu X, Wang T, et al
    Genetic and molecular underpinnings of the link between rheumatoid arthritis and myasthenia gravis: Insights from GWAS and transcriptomic analyses.
    Clin Rheumatol. 2025 Jul 19. doi: 10.1007/s10067-025-07582.
    PubMed     Abstract available
    
    
    
27. OZ B, Dogan Y, Karatas A, Koca SS, et al
    Radiological and serological predictors of cavitary transformation in rheumatoid arthritis-associated pulmonary nodules: a retrospective cohort study.
    Clin Rheumatol. 2025 Jul 19. doi: 10.1007/s10067-025-07579.
    PubMed     Abstract available
    
    
    
28. ZOU L, Fan Q, Liu Y, He H, et al
    Leucine-rich alpha-2-glycoprotein 1 (LRG1) decrement during biologics therapy and its correlation with disease features and treatment outcomes in rheumatoid arthritis patients.
    Clin Rheumatol. 2025 Jul 15. doi: 10.1007/s10067-025-07545.
    PubMed     Abstract available
    
    
    
29. REN Y, Xia W, Wu J, Yang Z, et al
    Artificial intelligence-based prediction of organ involvement in Sjogren's syndrome using labial gland biopsy whole-slide images.
    Clin Rheumatol. 2025;44:2919-2927.
    PubMed     Abstract available
    
    
    
30. CHENG F, Wang YL, Ai XY, Liu Y, et al
    Clinical features of anti-RNP-positive primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:2911-2917.
    PubMed     Abstract available
    
    
    
31. TURKMEN S, Coskuner T, Sozeri B
    Multidimensional assessment of Juvenile Sjogren disease.
    Clin Rheumatol. 2025;44:2897-2909.
    PubMed     Abstract available
    
    
    
32. GU X, Chen Y, Xuan J, Shi Y, et al
    Positive thyroid autoantibodies in primary Sjogren syndrome define a subset of patients with milder disease.
    Clin Rheumatol. 2025;44:2889-2895.
    PubMed     Abstract available
    
    
    
33. JONUSIENE G, Kaceniene A, Gedvilaite V, Dadoniene J, et al
    Cancer risk in patients with Sjogren's syndrome in Lithuanian cohort study.
    Clin Rheumatol. 2025;44:2883-2887.
    PubMed     Abstract available
    
    
    June 2025
34. EDITH SE, Miguel P, Gabriel RM, Maria O, et al
    Clinical variables and lung ultrasonography for the screening of interstitial lung disease in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Jun 24. doi: 10.1007/s10067-025-07510.
    PubMed     Abstract available
    
    
    
35. AKBARI AR, Alam B
    Medication effects on uric acid levels in rheumatoid arthritis studies.
    Clin Rheumatol. 2025 Jun 20. doi: 10.1007/s10067-025-07538.
    PubMed    
    
    
    
36. JIN J, Xiang X, Cai X, Hou Y, et al
    Machine learning and bioinformatics analysis to identify and validate diagnostic model associated with immune infiltration in rheumatoid arthritis.
    Clin Rheumatol. 2025 Jun 11. doi: 10.1007/s10067-025-07514.
    PubMed     Abstract available
    
    
    
37. KARACAOGLU MC, Kizildag B, Okyar B, Yildirim Cetin G, et al
    Computed tomography-based quantitative scoring system for rheumatoid arthritis-associated interstitial lung disease: a retrospective diagnostic accuracy study for progressive fibrosis detection.
    Clin Rheumatol. 2025 Jun 9. doi: 10.1007/s10067-025-07511.
    PubMed     Abstract available
    
    
    
38. OSKEN S, Osken A, Polat F, Sahin D, et al
    A retrospective study of electrocardiographic alterations in primary Sjogren's syndrome: role of anti-SSA positivity and disease duration.
    Clin Rheumatol. 2025;44:2377-2386.
    PubMed     Abstract available
    
    
    
39. SU R, Wang H, Li B, Wu R, et al
    Low-dose IL-2 restores Tfh/Tfr imbalance and modulates B cell subset distribution in the pre-arthritis phase of the collagen-induced arthritis model.
    Clin Rheumatol. 2025;44:2487-2500.
    PubMed     Abstract available
    
    
    
40. QI X, Zhao D, Wang N, Han Y, et al
    B lymphocyte subset-based stratification in primary Sjogren's syndrome: implications for lymphoma risk and personalized treatment.
    Clin Rheumatol. 2025;44:2403-2412.
    PubMed     Abstract available
    
    
    
41. DOU H, Wu R, Wang H, Wang X, et al
    CCR5 + T cells as a potential biomarker for primary Sjogren's disease based on bioinformatics analysis.
    Clin Rheumatol. 2025;44:2387-2401.
    PubMed     Abstract available
    
    
    
42. LUO Y, Mo Y, Li S, Yao J, et al
    Value of combined application of the OMERACT scoring system and shear wave elastography for primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:2367-2375.
    PubMed     Abstract available
    
    
    
43. FAN R, Zhang Z, Huang Q, Liu L, et al
    Association of regional adiposity distribution with risk of autoimmune diseases.
    Clin Rheumatol. 2025;44:2541-2552.
    PubMed     Abstract available
    
    
    
44. WANG C, Hu H, Xu Y, Wang S, et al
    Transcriptomic sequencing of multiple salivary glands combined with bioinformatics analysis reveals key genes in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:2355-2365.
    PubMed     Abstract available
    
    
    
45. WANG Z, Chen X, Zhang QB, Wang H, et al
    Exploring the genetic components and multi-omics sources of inflammatory bowel disease from the perspective of autoimmune disorders.
    Clin Rheumatol. 2025;44:2527-2539.
    PubMed     Abstract available
    
    
    
46. DUO R, Wang Y, Ma Q, Wang X, et al
    MTX-induced gastrointestinal reactions in RA: Prevotella enrichment, gut dysbiosis, and PI3K/Akt/Ras/AMPK pathways.
    Clin Rheumatol. 2025;44:2163-2177.
    PubMed     Abstract available
    
    
    May 2025
47. MUSTONEN AM, Savinainen J, Lehtonen M, Lehenkari P, et al
    Synovial fluid o-tyrosine is a potential biomarker for autoimmune-driven rheumatoid arthritis.
    Clin Rheumatol. 2025 May 31. doi: 10.1007/s10067-025-07491.
    PubMed     Abstract available
    
    
    
48. RAO P, Jin S, Qi Y, Liu X, et al
    Clinical significance of serum RAGE levels in anti-CCP-negative rheumatoid arthritis.
    Clin Rheumatol. 2025 May 22. doi: 10.1007/s10067-025-07493.
    PubMed     Abstract available
    
    
    
49. YAN L, Xu J, Ye X, Lin M, et al
    Development and validation of ultrasound-based radiomics deep learning model to identify bone erosion in rheumatoid arthritis.
    Clin Rheumatol. 2025 May 19. doi: 10.1007/s10067-025-07481.
    PubMed     Abstract available
    
    
    
50. ZHENG X, Ke X, Gao J, Zheng Z, et al
    The molecular basis of all-trans retinoic acid binding to the target genes involved in rheumatoid arthritis through network pharmacology and molecular docking.
    Clin Rheumatol. 2025 May 17. doi: 10.1007/s10067-025-07482.
    PubMed     Abstract available
    
    
    
51. WU T, Wang Y, Xia Y, Ji J, et al
    Identifying the genetic association between rheumatoid arthritis and the risk of infectious diseases.
    Clin Rheumatol. 2025 May 16. doi: 10.1007/s10067-025-07485.
    PubMed     Abstract available
    
    
    
52. PHAM TH, Do TTH, Nguyen TN, Luu LC, et al
    Characteristics of sarcopenia in patients with rheumatoid arthritis at a central university hospital in Hanoi, Vietnam: a cross-sectional study.
    Clin Rheumatol. 2025 May 15. doi: 10.1007/s10067-025-07469.
    PubMed     Abstract available
    
    
    
53. TEMIZ KARADAG D, Dogan S, Cakir O, Altintas Y, et al
    The potential of semi-quantitative and quantitative methods in predicting progression in rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2025 May 15. doi: 10.1007/s10067-025-07443.
    PubMed     Abstract available
    
    
    
54. GOMES-SILVA JM, Torres CP, Teixeira LR, Saraiva MDCP, et al
    Prospective Sham-Controlled trial: acupuncture for symptom-relieving in patients with Sjogren's disease.
    Clin Rheumatol. 2025;44:1971-1982.
    PubMed     Abstract available
    
    
    
55. LI X, Li Y, Luo Q, Yang W, et al
    Direct immunofluorescence of labial gland in diagnosis of Sjogren's disease.
    Clin Rheumatol. 2025;44:1961-1969.
    PubMed     Abstract available
    
    
    
56. YANG Y, Zhang Y, Liu K, Liu M, et al
    IFI27, a potential candidate molecular marker for primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1949-1960.
    PubMed     Abstract available
    
    
    April 2025
57. XU QY, Liu YQ, Tong WQ, Yin-Ruo YR, et al
    Comparison of the clinical efficacy and pharmacoeconomics of tofacitinib and adalimumab in Chinese patients with rheumatoid arthritis: An analysis based on propensity score matching.
    Clin Rheumatol. 2025 Apr 29. doi: 10.1007/s10067-025-07431.
    PubMed     Abstract available
    
    
    
58. MA Z, Wu S, Xiong LE, Zhong J, et al
    Interaction of nutritional and inflammatory levels on all-cause mortality among individuals with rheumatoid arthritis: a prospective cohort study.
    Clin Rheumatol. 2025 Apr 28. doi: 10.1007/s10067-025-07458.
    PubMed     Abstract available
    
    
    
59. YANG D, Chen J, He G, Zhou Z, et al
    Comparisons of [(68) Ga]Ga-FAPI-04 PET/CT with X-ray imaging in the assessment of patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Apr 28. doi: 10.1007/s10067-025-07414.
    PubMed     Abstract available
    
    
    
60. ZHAO P, Yuan K, Tang Z, Li Y, et al
    Investigation of hub-shared genes and regulatory mechanisms of rheumatoid arthritis and atherosclerosis.
    Clin Rheumatol. 2025 Apr 28. doi: 10.1007/s10067-025-07423.
    PubMed     Abstract available
    
    
    
61. MALEKAN M, Dozandeh-Jouybari A, Sadeghian N, Soltanshahi M, et al
    SLAM receptors regulate immune checkpoints via SAP and EAT- 2 in rheumatoid arthritis: association with disease activity.
    Clin Rheumatol. 2025 Apr 26. doi: 10.1007/s10067-025-07461.
    PubMed     Abstract available
    
    
    
62. WU Q, Zhang X, Qin M, Shi D, et al
    Dual roles of LncRNA RNA143598: a biomarker for rheumatoid arthritis and its implications in cancer.
    Clin Rheumatol. 2025 Apr 25. doi: 10.1007/s10067-025-07448.
    PubMed     Abstract available
    
    
    
63. CELIK NC, Kilinc EA
    Assessment of ChatGPT's adherence to EULAR diagnostic criteria and therapeutic protocols for rheumatoid arthritis at two distinct time points, 14 days apart, utilizing binary and multiple-choice inquiries.
    Clin Rheumatol. 2025 Apr 22. doi: 10.1007/s10067-025-07417.
    PubMed     Abstract available
    
    
    
64. THYBERG I, Husberg M, Kastbom A
    Physical and mental disability is evident 8 years after diagnosis in early rheumatoid arthritis despite contemporary medication and non-pharmacological interventions.
    Clin Rheumatol. 2025 Apr 9. doi: 10.1007/s10067-025-07399.
    PubMed     Abstract available
    
    
    
65. LEBOUILLE-VELDMAN AB, Huizinga TWJ, Mekary RA, Vleggeert-Lankamp CLA, et al
    Prolonged glucocorticoid use and rheumatoid arthritis-associated cervical spine deformity.
    Clin Rheumatol. 2025 Apr 4. doi: 10.1007/s10067-025-07408.
    PubMed     Abstract available
    
    
    
66. YANG J, Park Y, Lee JJ, Kim WU, et al
    Clinical value of salivary gland ultrasonography in evaluating secretory function, disease activity, and lymphoma risk factors in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1643-1652.
    PubMed     Abstract available
    
    
    
67. HAKBILEN S, Tezcan D, Onmaz DE, Yilmaz S, et al
    The role of CXCL9, CXCL10, and CXCL13 chemokines in patients with Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1635-1642.
    PubMed     Abstract available
    
    
    
68. HAN Y, Wang R, Sun F, Feng R, et al
    Anti-SSA/SSB antibody double-negative Sjogren's disease patients: a comprehensive clinical study and immune profile.
    Clin Rheumatol. 2025;44:1625-1633.
    PubMed     Abstract available
    
    
    
69. XU Y, Yin Y, Li W, Zhou J, et al
    Salvage treatment of AOSD-associated macrophage activation syndrome with bariticinib following conventional immunosuppressive therapy.
    Clin Rheumatol. 2025;44:1705-1712.
    PubMed     Abstract available
    
    
    March 2025
70. GENG L, Li T, Liu Y, Liu X, et al
    Lycium barbarum polysaccharide corrects CCR9(+) Th17/ Treg imbalance in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Mar 27. doi: 10.1007/s10067-025-07415.
    PubMed     Abstract available
    
    
    
71. LI F, Xian D, Yang K
    Mendelian randomization and mediation analysis reveal the role of immune cell subsets in the causal pathways between blood cell perturbation responses and rheumatoid arthritis.
    Clin Rheumatol. 2025 Mar 12. doi: 10.1007/s10067-025-07387.
    PubMed     Abstract available
    
    
    
72. ANGELOZZI L, Gillibert A, Brevet P, Grosjean J, et al
    Comparative analysis of clinical profile, therapeutic management, and clinical prognosis of patients with seropositive or seronegative rheumatoid arthritis following the introduction of a first targeted therapy in a real-life setting.
    Clin Rheumatol. 2025 Mar 10. doi: 10.1007/s10067-025-07390.
    PubMed     Abstract available
    
    
    
73. ZHAO C, Xiao Q, Huang W, Chen Y, et al
    Association between rheumatoid arthritis and hyperuricemia among adults: a cross-sectional study based on NHANES data.
    Clin Rheumatol. 2025 Mar 6. doi: 10.1007/s10067-025-07386.
    PubMed     Abstract available
    
    
    
74. YU X, Xi J, Wu J, Song R, et al
    Correlation between myocardial work and disease activity in rheumatoid arthritis patients with preserved left ventricular ejection fraction: a retrospective study based on non-invasive pressure-strain loop?.
    Clin Rheumatol. 2025 Mar 5. doi: 10.1007/s10067-025-07380.
    PubMed     Abstract available
    
    
    
75. SONG S, Yang Y, Ren T, Shen Y, et al
    Enhanced co-expression of TIGIT and PD-1 on gammadelta T cells correlates with clinical features and laboratory parameters in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1245-1257.
    PubMed     Abstract available
    
    
    
76. PEI W, Xu L, Zhong H, Wang Z, et al
    Clinical features of inflammatory arthritis in daily practice-China's perspective.
    Clin Rheumatol. 2025;44:969-978.
    PubMed     Abstract available
    
    
    
77. LIANG Y, Zhang Z, Li J, Yang Z, et al
    Association of increased serum I-309 with phenotypes, disease activity, and cytokine pattern in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1237-1243.
    PubMed     Abstract available
    
    
    
78. HUGHES DM, Yiu ZZN, Zhao SS
    External validation of the accuracy of cardiovascular risk prediction tools in psoriatic disease: a UK Biobank study.
    Clin Rheumatol. 2025;44:1151-1161.
    PubMed     Abstract available
    
    
    
79. PANG F, Jiang Q, Tang X, Li K, et al
    Fecal metabolomic analysis of the role of gut microbiota and short-chain fatty acids in the therapeutic mechanism of Timosaponin AIII in Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1209-1223.
    PubMed     Abstract available
    
    
    
80. LIANG P, Huang Y, Hu Z, Zhou L, et al
    Clinical and laboratory characteristics of Sjogren's syndrome-associated autoimmune liver disease: a real-world, 10-year retrospective study.
    Clin Rheumatol. 2025;44:1225-1236.
    PubMed     Abstract available
    
    
    
81. VIEGAS-COSTA LC, Friesen R, Lai H, McGaw T, et al
    Serology and histology in Sjogren's syndrome diagnosis: a retrospective accuracy study.
    Clin Rheumatol. 2025;44:1197-1207.
    PubMed     Abstract available
    
    
    February 2025
82. LI Y, Zhong S, Huang S, Zhong W, et al
    Application of metabolomics in the classification of traditional Chinese medicine syndromes in rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 26. doi: 10.1007/s10067-025-07373.
    PubMed     Abstract available
    
    
    
83. TASAMMA AT, Eshetu BZ, Seyoum AT, Woldegiorgis SA, et al
    Differences in rates of remission between rheumatoid factor positive and negative rheumatoid arthritis patients: experience from a resource-limited setting.
    Clin Rheumatol. 2025 Feb 25. doi: 10.1007/s10067-025-07370.
    PubMed     Abstract available
    
    
    
84. VISWANATHAN A, Brahma N, Vimal S
    The future of autoimmune disease care: merging genomic insights and imaging for enhanced prognosis in rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 22. doi: 10.1007/s10067-024-07234.
    PubMed    
    
    
    
85. SAIDI AN, Theel WB, Burggraaf B, van der Lelij AJ, et al
    Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 17. doi: 10.1007/s10067-025-07364.
    PubMed     Abstract available
    
    
    
86. WU H, Yin F, Wang Y, Tang Z, et al
    Increased macrophage migration inhibitory factor is associated with inflammation in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 14. doi: 10.1007/s10067-025-07361.
    PubMed     Abstract available
    
    
    
87. MIKAEILI B, Alqahtani ZA, Hincapie AL, Guo JJ, et al
    Safety of Janus kinase inhibitors in rheumatoid arthritis: a disproportionality analysis using FAERS database from 2012 to 2022.
    Clin Rheumatol. 2025 Feb 13. doi: 10.1007/s10067-025-07360.
    PubMed     Abstract available
    
    
    
88. MUSAEVA LM, Shestakova KM, Baskhanova SN, Varzieva VG, et al
    Evaluating treatment responsiveness in rheumatoid arthritis through predictive metabolomic profiling: A systematic review of studies examining methotrexate, TNF, and IL-6 inhibitors as therapeutic interventions.
    Clin Rheumatol. 2025 Feb 10. doi: 10.1007/s10067-025-07355.
    PubMed     Abstract available
    
    
    
89. NANKI T, Yamaguchi T, Umetsu K, Tanabe R, et al
    Development and validation of a prediction model for serious infections in rheumatoid arthritis patients treated with tocilizumab in Japan.
    Clin Rheumatol. 2025 Feb 7. doi: 10.1007/s10067-025-07328.
    PubMed     Abstract available
    
    
    
90. WANG H, Chu J, Wang Y, Wu Y, et al
    Mediating effect of X-26109 on the causal relationship between CD14(+) CD16(-) monocyte activation complex and rheumatoid arthritis in Europe.
    Clin Rheumatol. 2025 Feb 7. doi: 10.1007/s10067-025-07300.
    PubMed     Abstract available
    
    
    
91. HAMMAM N, El-Hadidi T, El-Hadidi K, Elsaman A, et al
    International overview on juvenile-, adult- and elderly-onset rheumatoid arthritis: The age at disease onset as a fundamental determinant of clinical presentation.
    Clin Rheumatol. 2025 Feb 6. doi: 10.1007/s10067-025-07356.
    PubMed     Abstract available
    
    
    
92. QWABE N, Paruk F, Mody GM
    Low prevalence of methotrexate intolerance in rheumatoid arthritis: a South African study.
    Clin Rheumatol. 2025 Feb 6. doi: 10.1007/s10067-025-07310.
    PubMed     Abstract available
    
    
    
93. XIE X, Wei G, Tang Z, Chen H, et al
    Investigating the causal relationship between rheumatoid arthritis and cardiovascular disease: A Mendelian randomization study.
    Clin Rheumatol. 2025 Feb 6. doi: 10.1007/s10067-025-07357.
    PubMed     Abstract available
    
    
    
94. WU B, Dong Q, Zhang Q, Jin F, et al
    Protective effects of Catalpol to attenuate TNF- alpha and collagen-induced inflammation in vitro HFLS-RA cells and in vivo mice models for the treatment of rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 5. doi: 10.1007/s10067-024-07261.
    PubMed     Abstract available
    
    
    
95. LONG D, Zhan J, Tu C, Yu S, et al
    Analysis of expression and its clinical significance of the ADAMTS-2 in systemic lupus erythematosus.
    Clin Rheumatol. 2025;44:681-691.
    PubMed     Abstract available
    
    
    
96. LIAO Q, Zhao Y, Li X, Li X, et al
    Cerebral venous thrombosis as a rare complication of Sjogren's syndrome: case series and literature review.
    Clin Rheumatol. 2025;44:739-746.
    PubMed     Abstract available
    
    
    January 2025
97. MOHAN A, Mohan A, Ramachandran A, Pulinilkunnathil JG, et al
    Anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease masquerading as rheumatoid arthritis-associated interstitial lung disease or overlapping with the same: a phenomenon driven by a probable genetic predispositio
    Clin Rheumatol. 2025 Jan 30. doi: 10.1007/s10067-025-07351.
    PubMed     Abstract available
    
    
    
98. UZUN GS, Sarikaya Y, Arslan S, Ekici M, et al
    ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Jan 30. doi: 10.1007/s10067-025-07344.
    PubMed     Abstract available
    
    
    
99. PERNIOLA S, Bruno D, Di Mario C, Campobasso D, et al
    Residual pain and fatigue are affected by disease perception in rheumatoid arthritis in sustained clinical and ultrasound remission.
    Clin Rheumatol. 2025 Jan 22. doi: 10.1007/s10067-025-07331.
    PubMed     Abstract available
    
    
    
100. HUANG Y, Li T, An Y, Lu D, et al
     Molecular mechanism of osteoclast differentiation of PBMC in patients with rheumatoid arthritis.
     Clin Rheumatol. 2025 Jan 18. doi: 10.1007/s10067-025-07322.
     PubMed     Abstract available
     
     
     
101. XU B, Yu C
     Letter to editor "Health?related quality of life (HRQoL) loss associated with self?perceived anxiety/depression in seropositive rheumatoid arthritis".
     Clin Rheumatol. 2025 Jan 17. doi: 10.1007/s10067-024-07260.
     PubMed    
     
     
     
102. SENER S, Sener YZ
     Letter to the editor: Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findi
     Clin Rheumatol. 2025 Jan 17. doi: 10.1007/s10067-025-07330.
     PubMed    
     
     
     
103. WU S, Xie Y, Jiang Y, Zhang X, et al
     GTS-21 modulates rheumatoid arthritis Th17 and Th2 lymphocyte subset differentiation through the a7nAch receptor.
     Clin Rheumatol. 2025 Jan 15. doi: 10.1007/s10067-025-07320.
     PubMed     Abstract available
     
     
     
104. HU X, Liu X, Xu Y, Zhang S, et al
     Machine learning-based prediction model integrating ultrasound scores and clinical features for the progression to rheumatoid arthritis in patients with undifferentiated arthritis.
     Clin Rheumatol. 2025 Jan 10. doi: 10.1007/s10067-025-07304.
     PubMed     Abstract available
     
     
     
105. ALRIFAI N, Puttur A, Ghanem F, Dhital Y, et al
     Maternal and fetal outcomes in those with autoimmune connective tissue disease.
     Clin Rheumatol. 2025;44:391-401.
     PubMed     Abstract available
     
     
     
106. KOPPEJAN H, Smith SI, Hameetman M, Toes REM, et al
     A small-scale preliminary study utilizing mass cytometry to distinguish two forms of arthritis.
     Clin Rheumatol. 2025;44:495-502.
     PubMed     Abstract available
     
     
     
107. MANDOSI C, Matys V, Deroma M, Del Negro V, et al
     Ovarian reserve in patients with Sjogren's syndrome: a cross-sectional study.
     Clin Rheumatol. 2025;44:319-325.
     PubMed     Abstract available
     
     
     
108. FAYET F, Beauvais C, Pereira B, Beranger M, et al
     Comparison of group versus individual patient education for promoting safety skills of patients with autoimmune rheumatic diseases treated with biologics: a multicentre randomised controlled trial.
     Clin Rheumatol. 2025;44:487-494.
     PubMed     Abstract available
     
     
     
109. PANG R, Ma X, Guo H, Qi X, et al
     Meta-analysis of mortality-associated factors in primary Sjogren's syndrome patients with interstitial lung disease.
     Clin Rheumatol. 2025;44:23-31.
     PubMed     Abstract available
     
     
     December 2024
110. TANG M, Du L, Peng J
     Urinary albumin-to-creatinine ratio for predicting risk of all-cause mortality and specific-cause mortality in patients with rheumatoid arthritis: evidence from NHANES 1999-2018.
     Clin Rheumatol. 2024 Dec 30. doi: 10.1007/s10067-024-07272.
     PubMed     Abstract available
     
     
     
111. ZHOU W, Yang Y, Su L
     Development and validation of predictive factors influencing rheumatoid arthritis associated with interstitial lung disease.
     Clin Rheumatol. 2024 Dec 26. doi: 10.1007/s10067-024-07282.
     PubMed     Abstract available
     
     
     
112. HIJJAWI N, Tout FS, Azaizeh B, Aljaafreh B, et al
     The role of vitamins D, B12, C, and K in modulating inflammation and disease management in rheumatoid arthritis: a comprehensive review.
     Clin Rheumatol. 2024 Dec 26. doi: 10.1007/s10067-024-07285.
     PubMed     Abstract available
     
     
     
113. WAN J, Cao X, Yang Y
     Decreased in-hospital mortality in shock patients with rheumatoid arthritis compared to those without: a retrospective analysis of a critical care database.
     Clin Rheumatol. 2024 Dec 24. doi: 10.1007/s10067-024-07280.
     PubMed     Abstract available
     
     
     
114. HARROLD LR, Bingham CO, Pope JE, O'Brien J, et al
     Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry.
     Clin Rheumatol. 2024 Dec 20. doi: 10.1007/s10067-024-07245.
     PubMed     Abstract available
     
     
     
115. ZHAN W, Li R, Xu X
     The relationship between low-carbohydrate diet score, dietary macronutrient intake, and rheumatoid arthritis: results from NHANES 2011-2016.
     Clin Rheumatol. 2024 Dec 16. doi: 10.1007/s10067-024-07269.
     PubMed     Abstract available
     
     
     
116. GUAJARDO-JAUREGUI N, Cardenas-de la Garza JA, Galarza-Delgado DA, Azpiri-Lopez JR, et al
     Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findings from a Mexican coh
     Clin Rheumatol. 2024 Dec 10. doi: 10.1007/s10067-024-07249.
     PubMed     Abstract available
     
     
     
117. YANG L, Wang X, Gu B, Su D, et al
     Identifying the genetic association between rheumatoid arthritis and the risk of pulmonary arterial hypertension.
     Clin Rheumatol. 2024 Dec 6. doi: 10.1007/s10067-024-07258.
     PubMed     Abstract available
     
     
     
118. FENG R, Xiao X, Wang Y, Huang B, et al
     Metabolic impact of low dose IL-2 therapy for primary Sjogren's Syndrome in a double-blind, randomized clinical trial.
     Clin Rheumatol. 2024;43:3789-3798.
     PubMed     Abstract available
     
     
     
119. SHUAI XU, Dandan F, Liang XU
     Study on the changes and significance of CXCL10 level in serum of isolated polymyalgia rheumatica.
     Clin Rheumatol. 2024;43:3993-3998.
     PubMed     Abstract available
     
     
     
120. TEIXEIRA RL, da Silva Vieira R, Saavedra MJ, Polido-Pereira J, et al
     Structured and prompt treatment of early arthritis in clinical practice leverages window of opportunity and leads to excellent clinical outcomes: an innovative retrospective cohort study.
     Clin Rheumatol. 2024;43:3941-3950.
     PubMed     Abstract available
     
     
     
121. WANG X, Wu H, Zhong B, Zhang L, et al
     Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sjogren's syndrome.
     Clin Rheumatol. 2024;43:3781-3787.
     PubMed     Abstract available
     
     
     
122. PENG LQ, Chen XH, Yang WJ, Huang WK, et al
     Can unstimulated whole salivary flow objectively classify salivary gland secretory function in Sjogren's syndrome?
     Clin Rheumatol. 2024;43:3771-3780.
     PubMed     Abstract available
     
     
     November 2024
123. PANG X, Xu F, Fan C, Jiang H, et al
     Global research trends of MicroRNAs in rheumatoid arthritis: bibliometrics and visualization analysis.
     Clin Rheumatol. 2024 Nov 28. doi: 10.1007/s10067-024-07250.
     PubMed     Abstract available
     
     
     
124. JIANG P, Shen Y, Chang C, Shi Y, et al
     HIPK3 hypomethylation as a potential epigenetic biomarker in rheumatic immune diseases with emphasis on rheumatoid arthritis.
     Clin Rheumatol. 2024 Nov 27. doi: 10.1007/s10067-024-07158.
     PubMed     Abstract available
     
     
     
125. YAN L, Lin M, Ye X, Li W, et al
     Prediction model for bone erosion in rheumatoid arthritis based on musculoskeletal ultrasound and clinical risk factors.
     Clin Rheumatol. 2024 Nov 9. doi: 10.1007/s10067-024-07219.
     PubMed     Abstract available
     
     
     
126. LYU Q, Ma L, Liu H, Shao H, et al
     Weight-adjusted waist index associated with bone mineral density in rheumatoid arthritis patients: a cross-sectional study.
     Clin Rheumatol. 2024 Nov 5. doi: 10.1007/s10067-024-07179.
     PubMed     Abstract available
     
     
     
127. DAGHOR-ABBACI K, Laraba N, Dahou-Makhloufi C, Mechid F, et al
     Disease activity score for still's disease.
     Clin Rheumatol. 2024;43:3273-3283.
     PubMed     Abstract available
     
     
     
128. CAI X, Jin J, Ye H, Xiang X, et al
     Altered serum metabolome is associated with disease activity and immune responses in rheumatoid arthritis.
     Clin Rheumatol. 2024 Nov 1. doi: 10.1007/s10067-024-07201.
     PubMed     Abstract available
     
     
     October 2024
129. MAHMOUD EM, Radwan A, Elsayed SA
     A prospective randomized-controlled non-blinded comparative study of the JAK inhibitor (baricitinib) with TNF-alpha inhibitors and conventional DMARDs in a sample of Egyptian rheumatoid arthritis patients.
     Clin Rheumatol. 2024 Oct 31. doi: 10.1007/s10067-024-07194.
     PubMed     Abstract available
     
     
     
130. ROJAS-GUALDRON DF, Franco-Salazar C, Gomez-Henck CA, Manrique-Castrillon MC, et al
     Health-related quality of life (HRQoL) loss associated with self-perceived anxiety/depression in seropositive rheumatoid arthritis.
     Clin Rheumatol. 2024 Oct 30. doi: 10.1007/s10067-024-07186.
     PubMed     Abstract available
     
     
     
131. D'ONOFRIO B, Selmi C, Gremese E
     Are seronegative patients with rheumatoid arthritis and clinically suspect arthralgia properly represented in randomized clinical trials?
     Clin Rheumatol. 2024 Oct 26. doi: 10.1007/s10067-024-07187.
     PubMed     Abstract available
     
     
     
132. LI S, Chen Z, Yu H, Chang W, et al
     Association of magnesium deficiency scores with risk of rheumatoid arthritis and osteoarthritis in adults: a cross-sectional population-based study.
     Clin Rheumatol. 2024 Oct 25. doi: 10.1007/s10067-024-07203.
     PubMed     Abstract available
     
     
     
133. TAHIR MW, Rosli Y, Leung C, Wysham KD, et al
     Frailty and its association with readmissions in patients with rheumatoid arthritis: A national readmissions database study.
     Clin Rheumatol. 2024 Oct 19. doi: 10.1007/s10067-024-07200.
     PubMed     Abstract available
     
     
     
134. SHIH PC, Hung PC, Leong PY, Hsu JN, et al
     Incidence and risk factors of discontinuation of tofacitinib and biologic disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis: A population-based cohort study.
     Clin Rheumatol. 2024 Oct 11. doi: 10.1007/s10067-024-07161.
     PubMed     Abstract available
     
     
     
135. ZHAO CN, Jiang LQ, Musonye HA, Meng SY, et al
     Associations of accelerated biological aging and metabolic heterogeneity of obesity with rheumatoid arthritis: a prospective cohort study.
     Clin Rheumatol. 2024 Oct 5. doi: 10.1007/s10067-024-07167.
     PubMed     Abstract available
     
     
     
136. MOVAHEDI M, Cui K, Tomlinson G, Cesta A, et al
     Functional disability and disease activity are affected by social determinants of health in patients with rheumatoid arthritis.
     Clin Rheumatol. 2024 Oct 4. doi: 10.1007/s10067-024-07148.
     PubMed     Abstract available
     
     
     
137. LIN Q, Zhang C, Huang H, Bai Z, et al
     TLR2 reprograms glucose metabolism in CD4(+) T cells of rheumatoid arthritis patients to mediate cell hyperactivation and TNF-alpha secretion.
     Clin Rheumatol. 2024 Oct 2. doi: 10.1007/s10067-024-07125.
     PubMed     Abstract available
     
     
     
138. XIA Z, Zong S, Zhou S, Rao Y, et al
     Rheumatoid arthritis and gliostatin: a two-sample Mendelian randomization analysis and RT-PCR validation.
     Clin Rheumatol. 2024 Oct 1. doi: 10.1007/s10067-024-07164.
     PubMed     Abstract available
     
     
     
139. PHAN K, Chou S, Lee AYS
     Isolated cutaneous panniculitis in Sjogren's disease exacerbated by COVID-19 illness.
     Clin Rheumatol. 2024;43:3257-3258.
     PubMed    
     
     
     September 2024
140. SHI X
     Letter to the editor: "Association of congestive heart failure with mortality in individuals with rheumatoid arthritis: a cohort study".
     Clin Rheumatol. 2024 Sep 30. doi: 10.1007/s10067-024-07150.
     PubMed    
     
     
     
141. ANJIKI K, Hayashi S, Ikuta K, Suda Y, et al
     JAK inhibitors inhibit angiogenesis by reducing VEGF production from rheumatoid arthritis-derived fibroblast-like synoviocytes.
     Clin Rheumatol. 2024 Sep 20. doi: 10.1007/s10067-024-07142.
     PubMed     Abstract available
     
     
     
142. ZHANG L, Shen Y
     Letter to the editor to "Prior herpes zoster occurrence and high-dose corticosteroids increase herpes zoster risk in rheumatoid arthritis patients receiving janus kinase inhibitors in a retrospective and observational study".
     Clin Rheumatol. 2024 Sep 19. doi: 10.1007/s10067-024-07112.
     PubMed    
     
     
     
143. OU Y, Wu J, Zhu Y, Qi X, et al
     Application of superb microvascular imaging technology in clinical disease activity of rheumatoid arthritis.
     Clin Rheumatol. 2024 Sep 12. doi: 10.1007/s10067-024-07119.
     PubMed     Abstract available
     
     
     
144. HAYASHI S, Nakano N, Tsubosaka M, Kamenaga T, et al
     Real-world study comparing the efficacy of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis.
     Clin Rheumatol. 2024 Sep 7. doi: 10.1007/s10067-024-07117.
     PubMed     Abstract available
     
     
     
145. SUAREZ-ALMAZOR ME, Ruiz JI, Lei X, Wu CF, et al
     Trends in the use of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and recently diagnosed colorectal, lung, or prostate cancer.
     Clin Rheumatol. 2024 Sep 4. doi: 10.1007/s10067-024-07135.
     PubMed     Abstract available
     
     
     
146. ZAYENI H, Sojoudi S, Ghanbari AM, Masooleh IS, et al
     The effect of radiation synovectomy with phosphorus-32 on the pain and swelling in 31 RA patients with resistant monoarthritis of the knee.
     Clin Rheumatol. 2024;43:2791-2798.
     PubMed     Abstract available
     
     
     August 2024
147. WANG X, Bai Y, Zou X, He X, et al
     Exploring the role of Life Essential 8 in patients diagnosed with systemic lupus erythematosus and rheumatoid arthritis.
     Clin Rheumatol. 2024 Aug 21. doi: 10.1007/s10067-024-07114.
     PubMed     Abstract available
     
     
     
148. MALANI K, Pradhan S, Roberts M, Saquib N, et al
     Joint effect of rheumatoid arthritis and diet quality on cardiovascular and mortality outcomes: insights from the Women's Health Initiative.
     Clin Rheumatol. 2024 Aug 4. doi: 10.1007/s10067-024-07092.
     PubMed     Abstract available
     
     
     
149. WANG X, Yang J, Yu LY, Zhang J, et al
     Effect of disease duration on the use of tofacitinib: a real-world study in elderly patients with rheumatoid arthritis.
     Clin Rheumatol. 2024 Aug 2. doi: 10.1007/s10067-024-07084.
     PubMed     Abstract available
     
     
     
150. CHEN DY
     Reply to "Letter to the Editor": Exploring Multidimensional Factors of Herpes Zoster Risk in Rheumatoid Arthritis Patients Undergoing JAK Inhibitor Treatment.
     Clin Rheumatol. 2024 Aug 2. doi: 10.1007/s10067-024-07087.
     PubMed    
     
     
     
151. JERIES H, Daood R, Naffaa ME
     Is interleukin-1 blockade a therapeutic option for patients with palindromic rheumatism?
     Clin Rheumatol. 2024;43:2715-2717.
     PubMed    
     
     
     
152. ZHU H, Wang Y, Wang G, Ling Y, et al
     The circular RNA hsa_circ_0045800 serves as a favorable biomarker in pathogenesis of sjogren's syndrome.
     Clin Rheumatol. 2024;43:2585-2594.
     PubMed     Abstract available
     
     
     July 2024
153. PARK E, Iqbal R, Giles JT, Bernstein EJ, et al
     Use of methotrexate and TNF inhibitors in patients with rheumatoid arthritis-associated interstitial lung disease: a survey of rheumatologists.
     Clin Rheumatol. 2024 Jul 31. doi: 10.1007/s10067-024-07068.
     PubMed    
     
     
     
154. GU H, Yan D, Li J, Long X, et al
     Trends and future projections of incidence rate and mortality of rheumatoid arthritis in China: a systematic analysis based on GBD 2021 data.
     Clin Rheumatol. 2024 Jul 29. doi: 10.1007/s10067-024-07083.
     PubMed     Abstract available
     
     
     
155. TONG B, Cheng W
     Letter to editor 'Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease'.
     Clin Rheumatol. 2024 Jul 22. doi: 10.1007/s10067-024-07075.
     PubMed    
     
     
     
156. ZHOU L, Xing Y, Li W
     Exploring multidimensional factors of herpes zoster risk in rheumatoid arthritis patients undergoing JAK inhibitor treatment.
     Clin Rheumatol. 2024 Jul 20. doi: 10.1007/s10067-024-07076.
     PubMed    
     
     
     
157. NOVELLA-NAVARRO M, Ruiz-Esquide V, Lopez-Juanes N, Chacur CA, et al
     Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.
     Clin Rheumatol. 2024 Jul 16. doi: 10.1007/s10067-024-07070.
     PubMed     Abstract available
     
     
     
158. CHEN PK, Chang SH, Chen YM, Chen HH, et al
     Prior herpes zoster occurrence and high-dose corticosteroids increase herpes zoster risk in rheumatoid arthritis patients receiving janus kinase inhibitors in a retrospective and observational study.
     Clin Rheumatol. 2024 Jul 2. doi: 10.1007/s10067-024-07041.
     PubMed     Abstract available
     
     
     
159. FAYET F, Darmant N, Lambert C, Pereira B, et al
     Effect of Argentine tango sessions on total physical activity time in patients with chronic inflammatory rheumatism: randomized, controlled, pilot study.
     Clin Rheumatol. 2024;43:2215-2221.
     PubMed     Abstract available
     
     
     
160. SOLTANI F, Khalaji A, Farzaneh R, Malek Mahdavi A, et al
     Performance of existing diagnostic criteria for palindromic rheumatism.
     Clin Rheumatol. 2024;43:2337-2342.
     PubMed     Abstract available
     
     
     
161. ANSARI N, Salesi M
     The association between primary Sjogren's syndrome and non-Hodgkin's lymphoma: a systematic review and meta-analysis of cohort studies.
     Clin Rheumatol. 2024;43:2177-2186.
     PubMed     Abstract available
     
     
     June 2024
162. WANG W, Xu Y, Zhou J, Zang Y, et al
     Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
     Clin Rheumatol. 2024 Jun 26. doi: 10.1007/s10067-024-07040.
     PubMed     Abstract available
     
     
     
163. JANAHIRAMAN S, Shahril NS, Jayaraj VJ, Ch'ng S, et al
     A hierarchical cluster analysis for clinical profiling of tofacitinib treatment response in patients with rheumatoid arthritis.
     Clin Rheumatol. 2024 Jun 26. doi: 10.1007/s10067-024-07035.
     PubMed     Abstract available
     
     
     
164. LIU F, Liu F, Wang H
     Association between Life's Essential 8 and rheumatoid arthritis.
     Clin Rheumatol. 2024 Jun 24. doi: 10.1007/s10067-024-07036.
     PubMed     Abstract available
     
     
     
165. VENKAT RK, Hayashi K, Juge PA, McDermott G, et al
     Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease.
     Clin Rheumatol. 2024 Jun 19. doi: 10.1007/s10067-024-07028.
     PubMed     Abstract available
     
     
     
166. GADEHOLT O, Arnold E, Gorman C, Mueller T, et al
     Body mass index stratification enables cytokine-based prediction of ACPA status and Power-Doppler disease activity in rheumatoid arthritis.
     Clin Rheumatol. 2024 Jun 14. doi: 10.1007/s10067-024-07032.
     PubMed     Abstract available
     
     
     
167. HARRIS JT, Yang Y, Bentley JP, Chen Y, et al
     Estimation of optimal adherence threshold for tumor necrosis factor inhibitors in rheumatoid arthritis.
     Clin Rheumatol. 2024 Jun 10. doi: 10.1007/s10067-024-06971.
     PubMed     Abstract available
     
     
     
168. OPDAM MAA, Broeder ND, van den Bemt BJF, Mulder K, et al
     Higher infection risk for JAK inhibitors tofacitinib and baricitinib compared to subcutaneous biological DMARDs.
     Clin Rheumatol. 2024;43:2133-2138.
     PubMed     Abstract available
     
     
     
169. SARIYILDIZ A, Coskun Benlidayi I, Yetisir A, Turk I, et al
     Central sensitization significantly deteriorates functionality and the interpretation of self-reported disease activity in primary Sjogren's syndrome.
     Clin Rheumatol. 2024;43:1949-1958.
     PubMed     Abstract available
     
     
     
170. GOLOVINA OA, Torgashina AV, Gorodetskiy VR, Sockol EV, et al
     Combination of Sjogren's syndrome and anti-Ku syndrome complicated by the development of mucosa-associated lymphoid tissue lymphoma: case review and systematic review of the literature.
     Clin Rheumatol. 2024;43:2145-2152.
     PubMed     Abstract available
     
     
     
171. LIU H, Yuan J, Tan X, Song W, et al
     Male patients with primary Sjogren's syndrome have unique clinical manifestations and circulating lymphocyte profiles.
     Clin Rheumatol. 2024;43:1927-1937.
     PubMed     Abstract available
     
     
     
172. XIE Y, Fan Y, Su M, Wang Y, et al
     Characteristics of the oral microbiota in patients with primary Sjogren's syndrome.
     Clin Rheumatol. 2024;43:1939-1947.
     PubMed     Abstract available
     
     
     
173. EL MIEDANY Y, El Gaafary M, Youssef S, El Aroussy N, et al
     Meaningful patient engagement in inflammatory arthritis: development of the Patient Motivation Questionnaire.
     Clin Rheumatol. 2024;43:1793-1801.
     PubMed     Abstract available
     
     
     May 2024
174. CHEN G, Chen H, Wang Z, Cai H, et al
     Letter to the editor: "Definition of follicular helper T cell and cytokines expression in synovial fluid of rheumatoid arthritis".
     Clin Rheumatol. 2024 May 18. doi: 10.1007/s10067-024-07006.
     PubMed    
     
     
     
175. ABDULSALAM AJ, Analay P, Kara M
     Sarcopenia in rheumatoid arthritis: choose your weapons wisely.
     Clin Rheumatol. 2024 May 13. doi: 10.1007/s10067-024-07002.
     PubMed    
     
     
     
176. MURPHY L, Saab MM, Cornally N, McHugh S, et al
     Cardiovascular disease risk assessment in patients with rheumatoid arthritis: A scoping review.
     Clin Rheumatol. 2024 May 11. doi: 10.1007/s10067-024-06996.
     PubMed     Abstract available
     
     
     
177. WAN J, Yu Z, Cao X, Zhao X, et al
     Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease.
     Clin Rheumatol. 2024 May 5. doi: 10.1007/s10067-024-06984.
     PubMed     Abstract available
     
     
     
178. HU W, Ding Y, Guan K, Zhang P, et al
     Changes in metabolic parameters and serum YKL-40 levels in Chinese rheumatoid arthritis patients during tocilizumab therapy.
     Clin Rheumatol. 2024 May 2. doi: 10.1007/s10067-024-06982.
     PubMed     Abstract available
     
     
     
179. XU N, Wang X, Dai T, Liu N, et al
     Non-invasive imaging for predicting labial salivary gland biopsy outcomes in patients with suspected primary Sjogren syndrome.
     Clin Rheumatol. 2024;43:1683-1692.
     PubMed     Abstract available
     
     
     
180. LU L, Dai T, Zhao Y, Qu H, et al
     The value of MRI-based radiomics for evaluating early parotid gland injury in primary Sjogren's syndrome.
     Clin Rheumatol. 2024;43:1675-1682.
     PubMed     Abstract available
     
     
     
181. CAI B, Guo Z, Yan Q, Li H, et al
     Clinical features and risk factors of primary Sjogren's syndrome complicated with severe pneumonia: a case-control study.
     Clin Rheumatol. 2024;43:1665-1674.
     PubMed     Abstract available
     
     
     
182. AN Q, Ma R, Yuan D, Huang J, et al
     Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia.
     Clin Rheumatol. 2024;43:1491-1501.
     PubMed     Abstract available
     
     
     
183. LI H, Jin Y, He J
     Respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease: a retrospective study.
     Clin Rheumatol. 2024;43:1777.
     PubMed    
     
     
     April 2024
184. SEPRIANO A, Ramiro S, Landewe R, van der Heijde D, et al
     Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort.
     Clin Rheumatol. 2024 Apr 29. doi: 10.1007/s10067-024-06978.
     PubMed     Abstract available
     
     
     
185. LOZADA-MELLADO M, Llorente L, Hinojosa-Azaola A, Ogata-Medel M, et al
     Inflammatory profile in patients with rheumatoid arthritis and sarcopenia.
     Clin Rheumatol. 2024 Apr 26. doi: 10.1007/s10067-024-06974.
     PubMed     Abstract available
     
     
     
186. SHEAHAN A, Anjohrin S, Suruki R, Stark JL, et al
     Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases.
     Clin Rheumatol. 2024 Apr 25. doi: 10.1007/s10067-024-06945.
     PubMed     Abstract available
     
     
     
187. LITTLEJOHN G, Anbumurali N, O'Sullivan C, Smith T, et al
     Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.
     Clin Rheumatol. 2024 Apr 18. doi: 10.1007/s10067-024-06967.
     PubMed     Abstract available
     
     
     
188. YETISIR A, Sariyildiz A, Turk I, Coskun Benlidayi I, et al
     Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors.
     Clin Rheumatol. 2024 Apr 15. doi: 10.1007/s10067-024-06963.
     PubMed     Abstract available
     
     
     
189. ZHOU J, Gan Y, Fan X, Qi H, et al
     Latent class analysis of psychological resilience and influencing factors in patients with rheumatoid arthritis: a cross-sectional survey.
     Clin Rheumatol. 2024 Apr 10. doi: 10.1007/s10067-024-06959.
     PubMed     Abstract available
     
     
     
190. YU T, Qian S, Li M
     Letter to the Editor: "Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis".
     Clin Rheumatol. 2024 Apr 6. doi: 10.1007/s10067-024-06924.
     PubMed    
     
     
     
191. OLIVEIRA D, Ferreira RM, Gomes CM, Vaz C, et al
     Geiser Sign in a patient with rheumatoid arthritis.
     Clin Rheumatol. 2024 Apr 4. doi: 10.1007/s10067-024-06952.
     PubMed    
     
     
     
192. XIE Y, Zhao H
     Real respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease.
     Clin Rheumatol. 2024;43:1353.
     PubMed    
     
     
     
193. DAI W, He H
     Commentary on the respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease.
     Clin Rheumatol. 2024;43:1419-1420.
     PubMed    
     
     
     
194. LIU X, Wang H, Wang X, Jiang X, et al
     Identification and verification of inflammatory biomarkers for primary Sjogren's syndrome.
     Clin Rheumatol. 2024;43:1335-1352.
     PubMed     Abstract available
     
     
     March 2024
195. BIRD A, Oakden-Rayner L, Smith LA, Zeng M, et al
     Prognostic modeling in early rheumatoid arthritis: reconsidering the predictive role of disease activity scores.
     Clin Rheumatol. 2024 Mar 27. doi: 10.1007/s10067-024-06946.
     PubMed     Abstract available
     
     
     
196. GUPTA N, Kanwar N, Arora A, Khatri K, et al
     The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches.
     Clin Rheumatol. 2024 Mar 18. doi: 10.1007/s10067-024-06932.
     PubMed     Abstract available
     
     
     
197. LU F, Chen Q, Qi X, Cong M, et al
     Revealing the changes in signaling pathways caused by tofacitinib in patients with rheumatoid arthritis through RNA sequencing and the correlation with clinical parameters.
     Clin Rheumatol. 2024 Mar 16. doi: 10.1007/s10067-024-06931.
     PubMed     Abstract available
     
     
     
198. HARADA H, Kondo M, Maeyama A, Fukuda T, et al
     Correction to: Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
     Clin Rheumatol. 2024 Mar 15. doi: 10.1007/s10067-024-06907.
     PubMed    
     
     
     
199. ATHANASSIOU P, Katsimbri P, Bounas A, Gazi S, et al
     Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational
     Clin Rheumatol. 2024 Mar 12. doi: 10.1007/s10067-024-06916.
     PubMed     Abstract available
     
     
     
200. OZ N, Gezer HH, Cilli Hayiroglu S, Duruoz MT, et al
     Evaluation of the prognostic nutritional index (PNI) as a tool for assessing disease activity in rheumatoid arthritis patients.
     Clin Rheumatol. 2024 Mar 11. doi: 10.1007/s10067-024-06927.
     PubMed     Abstract available
     
     
     
201. PAN J, Wu T, Ma JD, Jia PW, et al
     Geriatric nutrition risk index: a more powerful index identifying muscle mass loss in patients with rheumatoid arthritis.
     Clin Rheumatol. 2024 Mar 4. doi: 10.1007/s10067-024-06918.
     PubMed     Abstract available
     
     
     
202. SUZUKI S, Kataoka Y, Otani T, Taniguchi Y, et al
     Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature.
     Clin Rheumatol. 2024;43:1245-1251.
     PubMed     Abstract available
     
     
     
203. BOHMAN BR, Dowds HS, Blagogee TE, Ike RW, et al
     Sjogren's disease activity associates with cardiovascular disease and monoclonal gammopathy: a university cohort study of disease activity and comorbidities.
     Clin Rheumatol. 2024;43:1093-1101.
     PubMed     Abstract available
     
     
     
204. BAO X
     Validation of new immune and inflammation-related diagnostic biomarkers for RA.
     Clin Rheumatol. 2024;43:949-958.
     PubMed     Abstract available
     
     
     
205. ESPINOSA-BAUTISTA F, Salazar-Sanchez MI, Brianza-Padilla M, Leon-Avila G, et al
     Dysregulation of long non-coding RNAs in Takayasu arteritis: A proof-of-concept study.
     Clin Rheumatol. 2024;43:1253-1259.
     PubMed     Abstract available
     
     
     
206. PHAM C, Niu F, Hui RL, Le KN, et al
     Patient perceptions on switching from reference product adalimumab to biosimilar adalimumab-atto.
     Clin Rheumatol. 2024;43:1269-1270.
     PubMed    
     
     
     February 2024
207. CHEN D, Zhang J
     Commentary on the factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
     Clin Rheumatol. 2024 Feb 23. doi: 10.1007/s10067-024-06896.
     PubMed    
     
     
     
208. WANG B, Liu J, Zhao L
     Association of congestive heart failure with mortality in individuals with rheumatoid arthritis: a cohort study.
     Clin Rheumatol. 2024 Feb 20. doi: 10.1007/s10067-024-06878.
     PubMed     Abstract available
     
     
     
209. FERNANDEZ-AVILA DG, Patino-Hernandez D, Moreno-Luna S, Brance L, et al
     Development of a novel clinimetric tool: PAtient Reported Disease Activity Index in Rheumatoid Arthritis (PARDAI-RA) by PANLAR, for the assessment of patients living with rheumatoid arthritis.
     Clin Rheumatol. 2024 Feb 14. doi: 10.1007/s10067-024-06868.
     PubMed     Abstract available
     
     
     
210. LICHTIGER A, Fadaei G, Tagoe CE
     Autoimmune thyroid disease and rheumatoid arthritis: where the twain meet.
     Clin Rheumatol. 2024 Feb 10. doi: 10.1007/s10067-024-06888.
     PubMed     Abstract available
     
     
     
211. NOMAIR AM, Abdelati A, Dwedar FI, Elnemr R, et al
     The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients.
     Clin Rheumatol. 2024 Feb 5. doi: 10.1007/s10067-024-06892.
     PubMed     Abstract available
     
     
     
212. ZHANG L, Tan M, Mao J, Zhang J, et al
     Natural compound library screening to identify berberine as a treatment for rheumatoid arthritis.
     Clin Rheumatol. 2024 Feb 2. doi: 10.1007/s10067-024-06871.
     PubMed     Abstract available
     
     
     
213. LERCARA A, Malattia C, Hysa E, Gattorno M, et al
     Microvascular status in juvenile Sjogren's disease: the first nailfold videocapillaroscopy investigation.
     Clin Rheumatol. 2024;43:733-741.
     PubMed     Abstract available
     
     
     
214. ZHAO R, Dong C, Gu Z, Ding X, et al
     Development and validation of a nomogram for predicting fatigue in patients with primary Sjogren's syndrome.
     Clin Rheumatol. 2024;43:717-724.
     PubMed     Abstract available
     
     
     
215. ZHOU X, Li H, Wang N, Jin Y, et al
     Respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease: a retrospective study.
     Clin Rheumatol. 2024;43:707-715.
     PubMed     Abstract available
     
     
     
216. SHEN Y, Yu X, Wang Q, Yao X, et al
     Association between primary Sjogren's syndrome and gut microbiota disruption: a systematic review and meta-analysis.
     Clin Rheumatol. 2024;43:603-619.
     PubMed     Abstract available
     
     
     January 2024
217. O'BRIEN J, Park SH, Blachley T, Marchese M, et al
     Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups.
     Clin Rheumatol. 2024 Jan 25. doi: 10.1007/s10067-024-06869.
     PubMed     Abstract available
     
     
     
218. QIAO L, Lv S, Meng K, Yang J, et al
     Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study.
     Clin Rheumatol. 2024 Jan 10. doi: 10.1007/s10067-023-06837.
     PubMed     Abstract available
     
     
     
219. HARADA H, Kondo M, Maeyama A, Fukuda T, et al
     Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
     Clin Rheumatol. 2024 Jan 6. doi: 10.1007/s10067-023-06862.
     PubMed     Abstract available
     
     
     
220. SHIZUKU T, Hagino N
     Hypoglossal nerve palsy due to basilar impression in rheumatoid arthritis.
     Clin Rheumatol. 2024 Jan 3. doi: 10.1007/s10067-023-06863.
     PubMed    
     
     
     
221. YIN S, Luo F, Xie J, Zeng Y, et al
     Identification of discriminatory factors and construction of nomograms for differentiating AOSD and sepsis.
     Clin Rheumatol. 2024;43:569-578.
     PubMed     Abstract available
     
     
     
222. RUAN Y, Bi H, Luo X, Pang A, et al
     Elevated plasma levels of specific antiplatelet glycoprotein autoantibodies in patients with primary Sjogren syndrome with thrombocytopenia.
     Clin Rheumatol. 2024;43:307-314.
     PubMed     Abstract available
     
     
     
223. SAMI F, Sami SA, Manadan AM, Arora S, et al
     Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren's syndrome.
     Clin Rheumatol. 2024;43:59-65.
     PubMed     Abstract available
     
     
     
224. FARES J, Summer R, Loizidis G
     Low utilization of statins in patients with dermatomyositis/polymyositis and hyperlipidemia: a multicenter USA-based study (2013-2023).
     Clin Rheumatol. 2024;43:325-338.
     PubMed     Abstract available
     
     
     
225. CHEN L, Chi H, Teng J, Meng J, et al
     Neutralizing anti-IFN-gamma IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection.
     Clin Rheumatol. 2024;43:189-198.
     PubMed     Abstract available
     
     
     
226. ZHAO P, Peng C, Chang X, Cheng W, et al
     Decreased expression of TIGIT on CD14 + monocytes correlates with clinical features and laboratory parameters of patients with primary Sjogren's syndrome.
     Clin Rheumatol. 2024;43:297-306.
     PubMed     Abstract available
     
     
     
227. KIADALIRI A, Dell'Isola A, Englund M
     Inflammatory rheumatic diseases and the risk of drug use disorders: a register-based cohort study in Sweden.
     Clin Rheumatol. 2024;43:81-85.
     PubMed     Abstract available
     
     
     
228. CAI D, Zheng Z, Hu J, Fu Y, et al
     Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study.
     Clin Rheumatol. 2024;43:533-541.
     PubMed     Abstract available
     
     
     December 2023
229. SLOUMA M, Lahmar W, Mohamed G, Dhrif O, et al
     Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
     Clin Rheumatol. 2023 Dec 30. doi: 10.1007/s10067-023-06847.
     PubMed     Abstract available
     
     
     
230. WEMAN L, Salo H, Kuusalo L, Huhtakangas J, et al
     Similar levels of disease activity and remission rates in patients with psoriatic arthritis and rheumatoid arthritis-results from the Finnish quality register.
     Clin Rheumatol. 2023 Dec 28. doi: 10.1007/s10067-023-06850.
     PubMed     Abstract available
     
     
     
231. OZUDOGRU CELIK T
     Letter to the Editor on "The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients".
     Clin Rheumatol. 2023 Dec 27. doi: 10.1007/s10067-023-06823.
     PubMed    
     
     
     
232. YAGIZ B, Coskun BN, Halil EY, Dalkilic E, et al
     Rebuttal Letter to "The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients".
     Clin Rheumatol. 2023 Dec 27. doi: 10.1007/s10067-023-06856.
     PubMed    
     
     
     
233. D'ALESSANDRO F, Cazzato M, Laurino E, Morganti R, et al
     ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study
     Clin Rheumatol. 2023 Dec 23. doi: 10.1007/s10067-023-06836.
     PubMed     Abstract available
     
     
     
234. LIU H, Zhang Y, Cao J, Li J, et al
     Sema4D as a biomarker for Predicting rheumatoid arthritis disease activity.
     Clin Rheumatol. 2023 Dec 14. doi: 10.1007/s10067-023-06840.
     PubMed     Abstract available
     
     
     
235. MO H, Su ZH, Zheng ZY, Gao L, et al
     Screening for early rheumatoid arthritis using high-frequency ultrasound, serum RANKL, and OPG detection.
     Clin Rheumatol. 2023 Dec 5. doi: 10.1007/s10067-023-06830.
     PubMed     Abstract available
     
     
     
236. KARAMALI N, Mahmoudi Z, Roghani SA, Assar S, et al
     Overexpression of Synoviolin and miR-125a-5p, miR-19b-3p in peripheral blood of rheumatoid arthritis patients after treatment with conventional DMARDs and methylprednisolone.
     Clin Rheumatol. 2023 Dec 4. doi: 10.1007/s10067-023-06808.
     PubMed     Abstract available
     
     
     
237. HE J, Xu C, Zhu Y, Xu M, et al
     Clinical significance of the expression levels of serum transforming growth factor-beta and CXC type chemokine ligand 13 in primary Sjogren's syndrome patients.
     Clin Rheumatol. 2023;42:3283-3288.
     PubMed     Abstract available
     
     
     
238. SCHMIDT NS, Fana V, Danielsen MA, Lindegaard HM, et al
     The impact of an ultrasound atlas for scoring salivary glands in primary Sjogren's syndrome: a pilot study.
     Clin Rheumatol. 2023;42:3275-3281.
     PubMed     Abstract available
     
     
     
239. YIN H, Yang S, Lu L
     Adie's tonic pupil in primary Sjogren syndrome.
     Clin Rheumatol. 2023;42:3419-3420.
     PubMed    
     
     
     November 2023
240. SHAMSI A, Roghani SA, Soufivand P, Pournazari M, et al
     CXCL9 and NT-proBNP, a notable link between inflammatory mediator and cardiovascular disease biomarker in rheumatoid arthritis.
     Clin Rheumatol. 2023 Nov 25. doi: 10.1007/s10067-023-06826.
     PubMed     Abstract available
     
     
     
241. PALMOWSKI A, Strehl C, Pfeiffenberger M, Haupl T, et al
     Identification of gene expression biomarkers to predict clinical response to methotrexate in patients with rheumatoid arthritis.
     Clin Rheumatol. 2023 Nov 17. doi: 10.1007/s10067-023-06814.
     PubMed     Abstract available
     
     
     
242. RONG JC, Chen XD, Jin NK, Hong J, et al
     Exploring the causal association of rheumatoid arthritis with atrial fibrillation: a Mendelian randomization study.
     Clin Rheumatol. 2023 Nov 6. doi: 10.1007/s10067-023-06804.
     PubMed     Abstract available
     
     
     
243. HUANG Y, Qiu Y, Xie Z, Zhang F, et al
     Risk factors and prognosis of interstitial lung disease for primary Sjogren syndrome patients: A retrospective case?control study.
     Clin Rheumatol. 2023;42:3033-3041.
     PubMed     Abstract available
     
     
     
244. MASHAYEKHI M, Khalaji A, Malek Mahdavi A, Khabbazi A, et al
     Outcomes of undifferentiated peripheral inflammatory arthritis in real-world practice. A longitudinal cohort study.
     Clin Rheumatol. 2023;42:3143-3152.
     PubMed     Abstract available
     
     
     
245. SANTOS CS, Salgueiro RR, Morales CM, Castro CA, et al
     Risk factors for cardiovascular disease in primary Sjogren's syndrome (pSS): a 20-year follow-up study.
     Clin Rheumatol. 2023;42:3021-3031.
     PubMed     Abstract available
     
     
     
246. WISE L, Zell M
     Adult-onset Still's disease complicated by macrophage activation syndrome during pregnancy: a case-based review.
     Clin Rheumatol. 2023;42:3159-3166.
     PubMed     Abstract available
     
     
     October 2023
247. ADELOWO O, Omokhowa A, Ochiagha O, Uhunmwangho CU, et al
     Comorbidities in Nigerian patients with rheumatoid arthritis.
     Clin Rheumatol. 2023 Oct 23. doi: 10.1007/s10067-023-06797.
     PubMed     Abstract available
     
     
     
248. VALLEZ-VALERO L, Gaso-Gago I, Marcos-Fendian A, Garrido-Alejos G, et al
     Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib.
     Clin Rheumatol. 2023 Oct 13. doi: 10.1007/s10067-023-06787.
     PubMed     Abstract available
     
     
     
249. LI WJ, Wang XL, Chu YR, Wang JX, et al
     Association of sarcopenia and vitamin D deficiency with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
     Clin Rheumatol. 2023 Oct 13. doi: 10.1007/s10067-023-06784.
     PubMed     Abstract available
     
     
     
250. YAGIZ B, Coskun BN, Halil EY, Dalkilic E, et al
     The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients.
     Clin Rheumatol. 2023 Oct 9. doi: 10.1007/s10067-023-06780.
     PubMed     Abstract available
     
     
     
251. PAN S, Xiao X, Li T, Wu S, et al
     Definition of follicular helper T cell and cytokines expression in synovial fluid of rheumatoid arthritis.
     Clin Rheumatol. 2023 Oct 4. doi: 10.1007/s10067-023-06772.
     PubMed     Abstract available
     
     
     
252. TESCH F, Ehm F, Vivirito A, Wende D, et al
     Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study.
     Clin Rheumatol. 2023;42:2905-2914.
     PubMed     Abstract available
     
     
     
253. ZIMBA O, Gasparyan AY
     Cardiovascular issues in rheumatic diseases.
     Clin Rheumatol. 2023;42:2535-2539.
     PubMed     Abstract available
     
     
     
254. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
     Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
     Clin Rheumatol. 2023;42:2677-2690.
     PubMed     Abstract available
     
     
     September 2023
255. WEINSTEIN CLJ, Meehan AG, Lin J, Briscoe SD, et al
     Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
     Clin Rheumatol. 2023 Sep 26. doi: 10.1007/s10067-023-06760.
     PubMed     Abstract available
     
     
     
256. LIU H, Li Q, Long K, Xia O, et al
     Rheumatoid arthritis with pulmonary accelerated rheumatoid nodules treated by baricitinib: a case-based review.
     Clin Rheumatol. 2023 Sep 23. doi: 10.1007/s10067-023-06773.
     PubMed     Abstract available
     
     
     
257. NAKAYAMA M, Furuya T, Inoue E, Tanaka E, et al
     Factors associated with sarcopenia in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study.
     Clin Rheumatol. 2023 Sep 21. doi: 10.1007/s10067-023-06779.
     PubMed     Abstract available
     
     
     
258. RAZMJOU AA, Wang JM, Shahbazian A, Reddy S, et al
     Correction to: Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritis.
     Clin Rheumatol. 2023 Sep 14. doi: 10.1007/s10067-023-06768.
     PubMed    
     
     
     
259. CHEN YW, Chen HH, Huang WN, Chen JP, et al
     Potential alleviation of bone mineral density loss with Janus kinase inhibitors in rheumatoid arthritis.
     Clin Rheumatol. 2023 Sep 2. doi: 10.1007/s10067-023-06735.
     PubMed     Abstract available
     
     
     November 2022
260. CANSU DU, Korkmaz C
     Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
     Clin Rheumatol. 2022 Nov 17. pii: 10.1007/s10067-022-06446.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.